Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment
PR Newswire
ABBOTT PARK, Ill., Jan. 16, 2019
PR Newswire
ABBOTT PARK, Ill., Jan. 16, 2019
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey